APA

Derr R. S., van Hoesel A. Q., Benard A., Goossens-Beumer I. J., Sajet A., Dekker-Ensink N. G., de Kruijf E. M., Bastiaannet E., Smit V. T. H. B. M., van de Velde C. J. H. & Kuppen P. J. K. (20150420). High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients. : BMC cancer.

Chicago

Derr Remco S, van Hoesel Anneke Q, Benard Anne, Goossens-Beumer Inès J, Sajet Anita, Dekker-Ensink N Geeske, de Kruijf Esther M, Bastiaannet Esther, Smit Vincent T H B M, van de Velde Cornelis J H and Kuppen Peter J K. 20150420. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients. : BMC cancer.

Harvard

Derr R. S., van Hoesel A. Q., Benard A., Goossens-Beumer I. J., Sajet A., Dekker-Ensink N. G., de Kruijf E. M., Bastiaannet E., Smit V. T. H. B. M., van de Velde C. J. H. and Kuppen P. J. K. (20150420). High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients. : BMC cancer.

MLA

Derr Remco S, van Hoesel Anneke Q, Benard Anne, Goossens-Beumer Inès J, Sajet Anita, Dekker-Ensink N Geeske, de Kruijf Esther M, Bastiaannet Esther, Smit Vincent T H B M, van de Velde Cornelis J H and Kuppen Peter J K. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients. : BMC cancer. 20150420.